Senate Files

Bills

S. 4510 118th Congress

Kidney PATIENT Act of 2024

Latest action, Jun 11, 2024: Read twice and referred to the Committee on Finance.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

10 cosponsors

Sponsored by Marsha Blackburn (Republican). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
6 D · 4 R
  • Democrat
  • Republican
  • Independent
10 senators cosponsoring

Referred to: Senate: Finance Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

23 clientsQ1 2024Q4 2024

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

AKEBIA THERAPEUTICS, INC.
3 reports
AMERICAN KIDNEY FUND
3 reports
ARDELYX
RESOLUTION PUBLIC AFFAIRS, LLC
3 reports
ARDELYX, INC.
THORN RUN PARTNERS
3 reports
ARDELYX, INC.
3 reports
DAVITA INC
3 reports
FRESENIUS MEDICAL CARE NORTH AMERICA
AVENUE SOLUTIONS
3 reports
KIDNEY CARE PARTNERS
FEDERAL HEALTH POLICY STRATEGIES
3 reports
KIDNEY CARE PARTNERS
AVENUE SOLUTIONS
3 reports
NONPROFIT KIDNEY CARE ALLIANCE
HOOPER, LUNDY & BOOKMAN, P.C.
3 reports
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG
CROSSROADS STRATEGIES, LLC
3 reports
ARDELYX INC
THE HARPLE GROUP, LLC
2 reports
CORMEDIX INC.
2 reports
DAVITA, INC
APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
2 reports
DIALYSIS CLINIC, INC.
HOOPER, LUNDY & BOOKMAN, P.C.
2 reports
All 25 of 26 clients
ClientLobbying firmReportsReports totalingFromToSenate
AKEBIA THERAPEUTICS, INC.3$780KQ4 2024Q3 2024yes
AMERICAN KIDNEY FUND3$565KQ4 2024Q3 2024yes
ARDELYXRESOLUTION PUBLIC AFFAIRS, LLC3$0Q4 2024Q3 2024yes
ARDELYX, INC.THORN RUN PARTNERS3$0Q4 2024Q3 2024yes
ARDELYX, INC.3$1.9MQ4 2024Q3 2024yes
DAVITA INC3$3.2MQ4 2024Q3 2024yes
FRESENIUS MEDICAL CARE NORTH AMERICAAVENUE SOLUTIONS3$0Q4 2024Q3 2024yes
KIDNEY CARE PARTNERSFEDERAL HEALTH POLICY STRATEGIES3$120KQ4 2024Q3 2024yes
KIDNEY CARE PARTNERSAVENUE SOLUTIONS3$210KQ4 2024Q3 2024yes
NONPROFIT KIDNEY CARE ALLIANCEHOOPER, LUNDY & BOOKMAN, P.C.3$270KQ4 2024Q3 2024yes
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AGCROSSROADS STRATEGIES, LLC3$140KQ4 2024Q3 2024yes
ARDELYX INCTHE HARPLE GROUP, LLC2$0Q4 2024Q3 2024yes
CORMEDIX INC.2$300KQ4 2024Q3 2024yes
DAVITA, INCAPOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)2$0Q4 2024Q3 2024yes
DIALYSIS CLINIC, INC.HOOPER, LUNDY & BOOKMAN, P.C.2$40KQ4 2024Q3 2024yes
FRESENIUS MEDICAL CARE NORTH AMERICA2$2.8MQ4 2024Q3 2024yes
NATIONAL KIDNEY FOUNDATION2$185KQ4 2024Q3 2024yes
NATIONAL MINORITY QUALITY FORUM ACTION NETWORKINTEGRATED SOLUTIONS GROUP2$80KQ4 2024Q3 2024yes
THE ROGOSIN INSTITUTETHE FERRARO GROUP2$60KQ4 2024Q3 2024yes
ARDELYX, INC.CAPITOL CITY GROUP, LTD.1$0Q4 2024Q4 2024yes
ARDELYX, INC.ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)1$0Q4 2024Q4 2024yes
DAVITA INC.WEST FRONT STRATEGIES LLC1$0Q4 2024Q4 2024yes
DIALYSIS PATIENT CITIZENSKOUNTOUPES DENHAM CARR & REID, LLC1$0Q4 2024Q4 2024yes
DIALYSIS PATIENT CITIZENS1$500KQ2 2024Q2 2024yes
EARTHJUSTICE1$118KQ1 2024Q1 2024yes